{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:48:42Z","timestamp":1789170522311,"version":"build-2803163510"},"reference-count":87,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.cld.2022.06.014","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T20:51:28Z","timestamp":1666126288000},"page":"765-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Liver Transplantation for Primary Biliary Cholangitis"],"prefix":"10.1016","volume":"26","author":[{"given":"Eric F.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cld.2018.03.001","article-title":"Changes in the epidemiology of primary biliary cholangitis","volume":"22","author":"Lleo","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.26365","article-title":"Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study","volume":"58","author":"Mells","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"issue":"10003","key":"10.1016\/j.cld.2022.06.014_bib5","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib6","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1053\/gast.2002.32993","article-title":"The true impact of fatigue in primary biliary cirrhosis: a population study","volume":"122","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib7","first-page":"204","article-title":"Management of symptom complexes in primary biliary cholangitis","volume":"32","author":"Kuo","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib8","first-page":"145","article-title":"A\u00a0practical review of primary biliary cholangitis for the gastroenterologist","volume":"15","author":"Onofrio","year":"2019","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1478-3231.2009.02160.x","article-title":"Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up","volume":"30","author":"Bjornsson","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hep.21230","article-title":"Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence","volume":"44","author":"Newton","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1572-0241.2005.41315.x","article-title":"Evaluation of fatigue in U.S. patients with primary biliary cirrhosis","volume":"100","author":"Stanca","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2008.02.012","article-title":"Natural history of primary biliary cirrhosis","volume":"12","author":"Mayo","year":"2008","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cld.2018.03.005","article-title":"Understanding and treating pruritus in primary biliary cholangitis","volume":"22","author":"Carrion","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cld.2012.03.010","article-title":"Pruritus in chronic cholestatic liver disease","volume":"16","author":"Bunchorntavakul","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hep.510290229","article-title":"Quality of life before and after liver transplantation for cholestatic liver disease","volume":"29","author":"Gross","year":"1999","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.cld.2022.06.014_bib17","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1053\/j.gastro.2010.02.016","article-title":"Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosis","volume":"138","author":"Guanabens","year":"2010","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.cld.2022.06.014_bib18","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1572-0241.2000.02269.x","article-title":"Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation","volume":"95","author":"Trautwein","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1080\/00365520310000681a","article-title":"Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease","volume":"38","author":"Bjoro","year":"2003","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2022.06.014_bib20","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1359\/jbmr.2003.18.12.2190","article-title":"Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease","volume":"18","author":"Guichelaar","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib21","first-page":"913","article-title":"High incidence of vertebral osteoporotic fracture within the first year after liver transplantation","volume":"35","author":"Butin","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(94)90324-7","article-title":"Bone loss after orthotopic liver transplantation","volume":"97","author":"Meys","year":"1994","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib25","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","article-title":"Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study","volume":"147","author":"Lammers","year":"2014","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.cld.2022.06.014_bib28","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.cgh.2018.12.028","article-title":"Effects of age and Sex of response to ursodeoxycholic acid and transplant-free survival in patients with primary biliary cholangitis","volume":"17","author":"Cheung","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib29","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib30","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.06.014_bib31","unstructured":"Perez C, Fisher H, Hiu S, et\u00a0al. Patients with Primary Biliary Cholangitis Treated with Long-term Obeticholic Acid in a Trial-setting Demonstrate Better Transplant-free Survival than External Controls from the GLOBAL PBC and UK-PBC Study Groups. Oral Presentation at AASLD: The Liver Meeting 2021, Anaheim, California; November 12-15, 2021. 2021."},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.cld.2022.06.014_bib36","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2022.06.014_bib37","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib38","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1478-3231.2011.02678.x","article-title":"Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis","volume":"32","author":"Momah","year":"2012","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib40","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"Electronic address eee. EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib42","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American Society of transplantation","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.cld.2022.06.014_bib43","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00042737-200111000-00022","article-title":"Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy","volume":"13","author":"Neuberger","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2022.06.014_bib44","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/lt.25906","article-title":"Early predictors of Short-term prognosis in acute and acute severe autoimmune hepatitis","volume":"26","author":"Biewenga","year":"2020","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.cld.2022.06.014_bib46","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1111\/j.1600-6143.2011.03738.x","article-title":"Regional variability in symptom-based MELD exceptions: a response to organ shortage?","volume":"11","author":"Argo","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cgh.2017.09.062","article-title":"Twenty-year comparative analysis of patients with autoimmune liver diseases on transplant waitlists","volume":"16","author":"Webb","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib48","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.cgh.2017.12.017","article-title":"Increased waitlist mortality and lower rate for liver transplantation in hispanic patients with primary biliary cholangitis","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib49","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/tri.12877","article-title":"Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation","volume":"30","author":"Singal","year":"2017","journal-title":"Transplant Int"},{"issue":"10","key":"10.1016\/j.cld.2022.06.014_bib50","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.hpb.2018.03.013","article-title":"Waitlist mortality and post-transplant survival in patients with cholestatic liver disease - impact of changes in allocation policy","volume":"20","author":"Staufer","year":"2018","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.cld.2022.06.014_bib51","unstructured":"Available at: https:\/\/optn.transplant.hrsa.gov\/data\/. Accessed January 27, 2022."},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib52","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.21871","article-title":"Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom","volume":"46","author":"Corpechot","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0168-8278(99)80097-X","article-title":"Familial primary biliary cirrhosis reassessed: a geographically-based population study","volume":"30","author":"Jones","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10620-019-05786-1","article-title":"Outcomes of liver transplant candidates with primary biliary cholangitis: the data from the Scientific registry of transplant recipients","volume":"65","author":"Sayiner","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.cld.2022.06.014_bib57","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib59","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1600-6143.2010.03038.x","article-title":"Recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Silveira","year":"2010","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.cld.2022.06.014_bib60","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","author":"Charatcharoenwitthaya","year":"2007","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2013.04.017","article-title":"The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study","volume":"59","author":"Carbone","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib64","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jhep.2015.07.038","article-title":"Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence","volume":"63","author":"Bosch","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib65","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib66","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/ajt.13583","article-title":"Long-term outcomes of living-donor liver transplantation for primary biliary cirrhosis: a Japanese multicenter study","volume":"16","author":"Egawa","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.cld.2022.06.014_bib67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","author":"Jacob","year":"2006","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib68","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep4.1037","article-title":"Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: a Japanese multicenter retrospective study","volume":"1","author":"Kogiso","year":"2017","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib69","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2018.10.001","article-title":"Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival","volume":"156","author":"Montano-Loza","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib71","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1600-6143.2009.03006.x","article-title":"Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation","volume":"10","author":"Montano-Loza","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib72","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transplant"},{"issue":"11","key":"10.1016\/j.cld.2022.06.014_bib73","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","author":"Sanchez","year":"2003","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cld.2022.06.014_bib74","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","author":"Sylvestre","year":"2003","journal-title":"Liver Transplant"},{"issue":"10","key":"10.1016\/j.cld.2022.06.014_bib75","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.20511","article-title":"Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant","volume":"11","author":"Guy","year":"2005","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.20856","article-title":"Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis","volume":"13","author":"Morioka","year":"2007","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib77","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.dld.2020.12.005","article-title":"Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis","volume":"53","author":"Li","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2022.06.014_bib78","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transplant Int"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib79","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival","volume":"37","author":"Jacob","year":"2005","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib80","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","author":"Jacob","year":"2008","journal-title":"Ann Transplant"},{"issue":"6","key":"10.1016\/j.cld.2022.06.014_bib81","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/lt.25935","article-title":"Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis","volume":"27","author":"Pedersen","year":"2021","journal-title":"Liver Transplant"},{"issue":"1","key":"10.1016\/j.cld.2022.06.014_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","author":"Lucey","year":"2013","journal-title":"Liver Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2022.06.014_bib83","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lt.22410","article-title":"Present state of immunosuppressive therapy in liver transplant recipients","volume":"17","author":"Wiesner","year":"2011","journal-title":"Liver Transplant"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib84","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00007890-199602270-00007","article-title":"The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation","volume":"61","author":"Berlakovich","year":"1996","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cld.2022.06.014_bib85","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/lt.500040313","article-title":"Allograft rejection after liver transplantation for autoimmune liver diseases","volume":"4","author":"Hayashi","year":"1998","journal-title":"Liver Transplant Surg"},{"issue":"7","key":"10.1016\/j.cld.2022.06.014_bib86","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/TXD.0000000000000693","article-title":"Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid","volume":"3","author":"Satapathy","year":"2017","journal-title":"Transplant Direct"},{"issue":"4","key":"10.1016\/j.cld.2022.06.014_bib87","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.cgh.2016.07.035","article-title":"Acute rejection increases risk of graft failure and death in recent liver transplant recipients","volume":"15","author":"Levitsky","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2022.06.014_bib88","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/TP.0b013e3182845f6c","article-title":"Late acute liver allograft rejection; a study of its natural history and graft survival in the current era","volume":"95","author":"Thurairajah","year":"2013","journal-title":"Transplantation"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:00:41Z","timestamp":1761069641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1089326122000526"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.014","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Transplantation for Primary Biliary Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}